RECS
Columbia Research Enhanced Core ETF
RECS tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 5.8 B
ASSETS UNDER MGMT
15 bp
EXPENSES
Fund Basics
| Inception date | Sep 25, 2019 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| NVIDIA CORP | 9.0 % |
| APPLE INC | 8.7 % |
| MICROSOFT CORP | 6.4 % |
| ALPHABET INC. CLASS C | 3.5 % |
| META PLATFORMS INC | 2.4 % |
| PROCTER & GAMBLE CO/THE | 2.2 % |
| ALPHABET INC. CLASS A | 2.0 % |
| EXXON MOBIL CORP | 1.8 % |
| WELLS FARGO & CO | 1.6 % |
| BOOKING HOLDINGS INC. | 1.5 % |
Constituent Breakdown
| Number of holdings | 371 |
| Herfindahl-Hirschman Index | 263 |
| Wgt avg mkt cap (mns) | $1,314,145 |
| Large cap (>$10bn) | 91.9% |
| Mid cap ($2-10bn) | 3.9% |
| Small cap (<$2bn) | 0.1% |
| Developed mkts. | 95.9% |
| Emerging mkts. | 0.3% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 94.0 % |
 |
IRELAND | 0.8 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.1% | 25.3% | 18.4% | 21.5% | 9.0% | -- | -- | 12.5% |
| Dividend Yield | 0.0% | 1.4% | 1.3% | 1.3% | 5.3% | -- | -- | 4.4% |
| Total Returns | 7.1% | 26.7% | 19.7% | 22.8% | 14.3% | -- | -- | 16.8% | Ann. Volatility | 13.4% | 11.8% | 16.0% | 14.6% | 16.4% | -- | -- | 19.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.96 | 92% |
| MSCI EAFE | 0.59 | 57% |
| MSCI Emg Mkts | 0.42 | 50% |
Liquidity Measures
| Avg. volume (000) | 486 |
| ADV traded (mns) | $21 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.06% |
Technical Indicators
| 30d moving avg. (EMA) | $42.46 |
| Relative strength (RSI) | 64 |
| MACD/Signal | 0.55/0.52 |
| Bollinger Bands (Upper/Lower) | $43.81/$41.80 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. RECS |
Expenses vs. RECS |
ALTAR Score™ vs. RECS |
|---|---|---|---|---|
| REVS | Columbia Research Enhanced Value ETF | 54.6% | +4 bp | +1.3% |
| SNPE | Xtrackers S&P 500 ESG ETF | 50.4% | -5 bp | -1.1% |
| USNZ | Xtrackers Net Zero Pathway Paris Aligned US Equity ETF | 48.8% | -5 bp | -1.3% |
| SPXN | ProShares S&P 500 Ex-Financials ETF | 48.8% | -6 bp | -1.5% |
| QLC | FlexShares US Quality Large Cap Index Fund | 48.3% | +10 bp | -0.9% |
| QVML | Invesco S&P 500 QVM Multi-factor ETF | 48.0% | -4 bp | -1.2% |
| AAEQ | Alpha Architect US Equity 2 ETF | 47.6% | 0 bp | -1.6% |
| MGC | Vanguard Mega Cap ETF | 47.5% | -8 bp | -1.7% |
| CATH | Global X S&P 500 Catholic Values Custom ETF | 47.3% | +14 bp | -1.5% |
| ESGV | Vanguard ESG U.S. Stock ETF | 47.3% | -6 bp | -1.4% |
Risk and Returns: RECS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.0%
ALTAR SCORE™
64th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. RECS's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places RECS in the 64th percentile
among funds in the category.
Sell-Side Consensus
$49.65
PRICE TARGET
+13.2%
UPSIDE